8kg baby with pneumonia INJ pipzo dosing
Reading File
Quick answer: Piperacillin-tazobactam (Pip-Tazo) in pediatric pneumonia is typically dosed at 100 mg/kg/dose of the piperacillin component, every 8 hours IV. For an 8 kg child: 800 mg piperacillin component per dose, every 8 hours. Standard formulation is 4:1 ratio (piperacillin:tazobactam), so this equals ~112.5 mg/kg/day of tazobactam component.
Searching sources...
Finding Sources
Searching the Web
piperacillin tazobactam pediatric pneumonia dosing mg/kg 2024
Here is the complete dosing guide for Inj. Piperacillin-Tazobactam (Pip-Tazo) in an 8 kg child with pneumonia:
INJ Pip-Tazo Dosing - 8 kg Child, Pneumonia
Age Consideration
An 8 kg child is typically >9 months of age (median ~9-12 months+). Dosing below assumes age >9 months. If 2-9 months old, use the lower age bracket dose.
Dose (Piperacillin component basis)
| Scenario | Dose | Frequency | Per dose for 8 kg |
|---|---|---|---|
| Community-acquired / moderate pneumonia | 100 mg/kg/dose | Q8H | 800 mg (pip component) |
| Nosocomial / severe pneumonia | 100 mg/kg/dose | Q6H | 800 mg (pip component) |
- Doses are expressed as the piperacillin component (standard 8:1 ratio vials - piperacillin:tazobactam)
- Max dose: 4000 mg piperacillin component per dose (not a concern at 8 kg)
What to Order (Practical)
Standard vial: Pip-Tazo comes as 4.5 g vial = 4000 mg piperacillin + 500 mg tazobactam (8:1 ratio)
For 8 kg:
- 800 mg piperacillin + 100 mg tazobactam = 900 mg total pip-tazo per dose
- This is ~1/5 of a 4.5 g vial per dose
Practical order: Piperacillin-Tazobactam 900 mg IV (= pip 800 mg + taz 100 mg) every 8 hours (moderate) or every 6 hours (severe/nosocomial pneumonia)
Administration
- Reconstitute with NS (0.9% NaCl), typically to 100 mg/mL concentration
- Infuse over 30 minutes (standard)
- For resistant organisms or critically ill: consider extended infusion over 3-4 hours - this achieves significantly better pharmacodynamic target attainment against organisms with higher MICs
Age <9 Months (if applicable for this 8 kg baby)
| Indication | Dose | Frequency | Per dose for 8 kg |
|---|---|---|---|
| Moderate infection | 80 mg/kg/dose (pip) | Q8H | 640 mg |
| Nosocomial pneumonia | 80 mg/kg/dose (pip) | Q6H | 640 mg |
Key Notes
- Renal adjustment: No adjustment needed if eGFR ≥40 mL/min/1.73m². Reduce if eGFR <40.
- No hepatic adjustment needed (unless cirrhosis - rare in this age group).
- Coverage: Gram-negatives including Pseudomonas, gram-positives, anaerobes, many beta-lactamase producers. Does NOT cover MRSA - add vancomycin if MRSA suspected.
- If organism MIC is borderline or patient is critically ill, use Q6H dosing + extended 3-4 hour infusion for optimal pharmacodynamics.
Summary for quick reference:
INJ Pip-Tazo 900 mg (piperacillin 800 mg + tazobactam 100 mg) IV Q8H for community pneumonia, or Q6H for severe/nosocomial pneumonia, in an 8 kg child >9 months.
Vaginal itching treatment
Reading File
Quick answer: Vaginal itching treatment depends on the cause - the three most common are vulvovaginal candidiasis (antifungals), bacterial vaginosis (metronidazole), and trichomoniasis (metronidazole). Atrophic vaginitis in postmenopausal women responds to topical estrogen. Contact/allergic causes need allergen avoidance.
Searching sources...
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Here is a complete, cause-based treatment guide for vaginal itching (vulvovaginal pruritus):
Vaginal Itching - Treatment by Cause
The three most common infectious causes are vulvovaginal candidiasis, bacterial vaginosis (BV), and trichomoniasis. Non-infectious causes include atrophic vaginitis, contact dermatitis, and others. Accurate diagnosis before treatment is important - self-diagnosis is often incorrect.
1. Vulvovaginal Candidiasis (Most Common Cause of Itching)
Hallmarks: Vulvar pruritus, thick white "cottage cheese" discharge, vulvar erythema/fissures, vaginal pH ≤4.5, KOH prep shows pseudohyphae.
Treatment Options (Uncomplicated)
| Agent | Formulation | Regimen |
|---|---|---|
| Fluconazole (oral) | 150 mg tablet | Single dose PO (preferred by most patients) |
| Clotrimazole | 1% cream | 1 applicator intravaginally nightly x 7 days |
| Clotrimazole | 2% cream | 1 applicator intravaginally nightly x 3 days |
| Miconazole | 2% cream | 1 applicator intravaginally nightly x 7 days |
| Miconazole | 4% cream | 1 applicator intravaginally nightly x 3 days |
| Butoconazole | 2% cream | 1 applicator intravaginally nightly x 3 days |
| Terconazole | 0.4% cream | 1 applicator intravaginally nightly x 7 days |
| Terconazole | 0.8% cream / 80 mg suppository | Nightly x 3 days |
| Tioconazole | 6.5% ointment | Single intravaginal dose |
| Nystatin | 100,000-unit tablet | 1 tablet vaginally nightly x 14 days |
- Topical azoles are 80-90% effective; nystatin is less effective than azoles
- Fluconazole 150 mg PO single dose is the preferred oral option - equally effective, convenient
- Pregnancy: Use only topical azoles x 7 days; oral fluconazole is contraindicated
- Treating sexual partners is NOT routinely needed
- For C. glabrata (azole-resistant): nystatin intravaginal suppositories
Recurrent/Complicated Candidiasis
- Oral fluconazole 150 mg every 72 hours x 3 doses, then weekly x 6 months (suppressive)
- Refer to CDC STI guidelines for full management
2. Bacterial Vaginosis (BV)
Hallmarks: Malodorous thin gray-white discharge, "fishy" odor (+ whiff test), vaginal pH >4.5, clue cells on wet mount. Itching is less prominent than in candidiasis; malodor is the main complaint.
Treatment (Nonpregnant Women)
| Drug | Route | Regimen |
|---|---|---|
| Metronidazole 500 mg | Oral | Twice daily x 7 days |
| Metronidazole gel 0.75% | Intravaginal | 5 g once daily x 5 days |
| Clindamycin cream 2% | Intravaginal | 5 g at bedtime x 7 days |
- Pregnancy: Same oral or topical regimens are acceptable
- Treating male sexual partners is NOT beneficial
- Vaginal Lactobacillus/probiotic preparations are of no proven benefit
3. Trichomoniasis
Hallmarks: Profuse yellow-green frothy discharge, vulvar itching/irritation, erythema, vaginal pH ≥5, motile trichomonads on wet mount.
Treatment
| Drug | Regimen |
|---|---|
| Metronidazole 500 mg PO x 7 days | Preferred (more effective than single dose) |
| Metronidazole 2 g PO single dose | Standard but slightly less effective |
| Tinidazole 2 g PO single dose | Alternative; fewer GI side effects, longer half-life; useful for metronidazole-resistant cases |
- Must treat sexual partner(s) - significantly reduces reinfection risk (standard of care)
- Intravaginal metronidazole gel is NOT reliable for trichomoniasis - systemic treatment required
- Pregnancy: Oral metronidazole is still recommended (no proven harm); tinidazole avoided in pregnancy
4. Atrophic Vaginitis (Postmenopausal)
Cause: Estrogen deficiency causing thinning of vaginal epithelium. Affects 10-40% of postmenopausal women. Symptoms: dryness, irritation, itching, dyspareunia.
Treatment
| Option | Notes |
|---|---|
| Vaginal estrogen cream | First-line; 3x/week initially, taper to maintenance |
| Vaginal estrogen tablets | Equally effective, well tolerated |
| Vaginal estrogen ring (Estring) | Slow-release silicone ring, changed every 3 months |
| Ospemifene (SERM) | Oral option; FDA-approved for atrophic vaginitis + dyspareunia; main side effect: hot flashes |
| Water-based lubricants | Adjunct for dyspareunia; not curative |
- Systemic absorption with vaginal estrogen is minimal - no routine progestin needed
- Unlike vasomotor symptoms, atrophic vaginitis does not improve spontaneously; treatment is progressive
5. Other / Non-Infectious Causes
| Cause | Management |
|---|---|
| Contact dermatitis / allergy | Remove allergen (soaps, douches, spermicides, latex condoms, synthetic fabrics); topical low-potency corticosteroid for symptom relief |
| Lichen sclerosus | Topical high-potency corticosteroid (clobetasol) |
| Desquamative inflammatory vaginitis | 2% clindamycin cream ± topical steroid for several weeks |
| Retained foreign body | Remove foreign body |
| HSV (genital herpes) | Antiviral (acyclovir/valacyclovir) |
| Pinworm (Enterobius) | Mebendazole or albendazole |
| Psoriasis / eczema | Topical steroids, emollients |
Quick Diagnostic Differentiator
| Feature | Candidiasis | BV | Trichomoniasis |
|---|---|---|---|
| Discharge | White, clumped ("cottage cheese") | Thin gray-white | Profuse, yellow-green, frothy |
| Odor | None | Fishy | May be fishy |
| pH | ≤4.5 | >4.5 | ≥5 |
| Itching | Prominent | Mild/absent | Present |
| Wet prep | Pseudohyphae (KOH) | Clue cells | Motile trichomonads |
Sources: Harrison's Principles of Internal Medicine 22E, Rosen's Emergency Medicine, Tintinalli's Emergency Medicine, Textbook of Family Medicine 9e
This is a shared conversation. Sign in to Orris to start your own chat.